Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain

Journal of Infection

Volumn 55, Issue 3, 2007, Pages 260-266

  Oteo, Jesús ^a   García Estébanez, Carmen ^a   Migueláñez, Silvia ^a   Campos, José ^a   Martí, Sara ^b   Vila, Jordi ^b   Domínguez, Ma Ángeles ^c   Docobo, Fernando ^d   Larrosa, Nieves ^e   Pascual, Álvaro ^f   Pintado, Vicente ^g   Coll, Pere ^h  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Acinetobacter baumannii; Imipenem resistance; Molecular epidemiology

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION; SPAIN; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FEMALE; HOSPITALS; HUMANS; IMIPENEM; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; SPAIN; VARIATION (GENETICS);

EID: 34547839187     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.04.009     Document Type: Article

References (32)

1. Aygun G., Demirkiran O., Utku T., Mete B., Urkmez S., Yilmaz M., et al. Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect 52 (2002) 259-262
2. Quinn J.P. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis 27 Suppl. 1 (1998) S117-S124
3. Fournier P.E., and Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 42 (2006) 692-699
4. Manikal V.M., Landman D., Saurina G., Oydma E., Lal H., and Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 31 (2000) 101-106
5. El Shafie S.S., Alishaq M., and Leni Garcia M. Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit. J Hosp Infect 56 (2004) 101-105
6. Corbella X., Montero A., Pujol M., Domínguez M.A., Ayats J., Argerich M.J., et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38 (2000) 4086-4095
7. Gales A.C., Jones R.N., Forward K.R., Linares J., Sader H.S., and Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stentrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 32 Suppl. 2 (2001) 104-113
8. Go E.S., Urban C., Burns J., Kreiswirth B., Eisner W., Mariano N., et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet North Am Ed 344 (1994) 1329-1332
9. Álvarez-Lerma F., Palomar M., Insausti J., Olaechea P., Cerda E., Castillo F., et al. Infections caused by Acinetobacter spp. in critically ill ICU patients. Enferm Infect Microbiol Clin 23 (2005) 533-539
10. Acar J.F. Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis 24 Suppl. (1997) S17-S18
11. Ayan M., Durmaz R., Aktas E., and Durmaz B. Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital. J Hosp Infect 54 (2003) 39-45
12. Bergogne B., Berezin E., and Towner K.J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9 (1996) 148-165
13. Landman D., Quale J.M., Mayorga D., Adedeji A., Vangala K., Ravishankar J., et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn. NY. Arch Intern Med 162 (2002) 1515-1520
14. Gales A.C., Jones R.N., Forward K.R., Linares J., Sader H.S., and Verhoef J. Emerging importance of multidrug Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 32 (2001) S104-S113
15. Mahgoub S., Ahmed J., and Glatt A.E. Underlying characteristics of patients harbouring highly resistant Acinetobacter baumannii. Am J Infect Control 30 (2002) 386-390
16. Smolyakov R., Borer A., Riesenberg K., Schlaeffer F., Alkan M., Porath A., et al. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54 (2003) 32-38
17. Vila J., Ruiz J., Navia M., Becerril B., Garcia I., Perea S., et al. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol 37 (1999) 758-761
18. Abbo A., Navon-Venezia S., Hammer-Muntz O., Krichali T., Siegman-Igra Y., and Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 11 (2005) 22-29
19. Cisneros J.M., Rodríguez-Baño J., Fernández-Cuenca F., Ribera A., Vila J., Pascual A., et al. Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect 11 (2005) 874-879
20. Coelho J.M., Turton J.F., Kaufmann M.E., Glover J., Woodford N., Warner M., et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 44 (2006) 3623-3627
21. Reina R., Estenssoro E., Sáenz G., Canales H.S., Gonzalvo R., Vidal G., et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med 31 (2005) 1058-1065
22. Garnacho-Montero J., Ortiz-Leyba C., Jiménez-Jiménez F.J., Barrero-Almodóvar A.E., García-Garmendia J.L., Bernabeu-WittelI M., et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem susceptible VAP. Clin Infect Dis 36 (2003) 1111-1118
23. Kallel H., Bahloul M., Hergafi L., Akrout M., Ketata W., Chelly H., et al. Colistin as salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int J Antimicrob Agents 28 (2006) 366-369
24. Mutters R. Acinetobacter, Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative gram-negative rods. In: Murray P.R. (Ed). Manual of clinical microbiology. 7th edn (1999), American Society for Microbiology, Washington 539-560
25. Vaneechoute M., Dijkshoorn L., Tjernberg I., Elaichouni A., de Vos P., Claeys G., et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 33 (1995) 11-15
26. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing - 15th informational supplement, Approved Standard M100-S14 (2005), CLSI, Wayne, PA, USA
27. Hunter P.R., and Gaston M.A. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol 26 (1988) 2465-2466
28. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
29. Murray C.K., and Hospenthal D.R. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis 18 (2005) 502-506
30. Rodriguez-Baño J., Cisneros J.M., Fernandez-Cuenca F., Ribera A., Vila J., Pascual A., et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 25 (2004) 819-824
31. Fernandez-Cuenca F., Pascual A., Ribera A., Vila J., Bou G., Cisneros J.M., et al. Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000). Enferm Infecc Microbiol Clin 22 (2004) 267-271
32. Da Silva G, Dijkshoorn L, van der Reijden T, van Strijen B, Duarte A. Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II. Clin Microbiol Infect 2007;13:190-5.